Average Co-Inventor Count = 2.43
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. H. Lundbeck A/s (4 from 507 patents)
2. Takeda Pharmaceuticals U.s.a., Inc. (23 patents)
3. Takeda Pharmaceuticals North America, Inc. (1 patent)
4 patents:
1. 11628166 - Therapeutic uses of compounds having combined sert, 5-HT3 and 5-HT1a activity
2. 9744166 - [object Object]
3. 8722684 - 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of cognitive impairment
4. 8664225 - 1-[2-(2,4-dimethylphenylsulfanyl)-phenyl] piperazine as a compound with combined serotonin reuptake, 5-HT3 and 5-HT1A activity for the treatment of pain or residual symptoms in depression relating to sleep and cognition